Lipitor

Global Race in Drug Discovery Accelerates as Biotech Faces Economic and Regulatory Pivot

Clinical breakthroughs that nearly double survival rates in previously intractable diseases—such as Revolution Medicine’s targeted therapy daraxonrasib for pancreatic cancer—are…

Read More »